# Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis

> **NCT02251093** · PHASE3 · COMPLETED · sponsor: **Probionov** · enrollment: 350 (actual)

## Conditions studied

- Candidiasis, Vulvovaginal

## Interventions

- **DRUG:** Lcr Regenerans
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02251093
- **Lead sponsor:** Probionov
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2016-02
- **Final completion:** —
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2016-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02251093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02251093, "Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02251093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*